Ropeginterferon alfa-2b Clinical Trials

2 actively recruiting trials across 1 location

▼ -1 trial since July 2026

Also known as: Besremi, P1101

Pipeline

Phase 1: 1

Top Sponsors

H. Lee Moffitt Cancer Center and Research Institute1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1

Indications

Cancer2
Cutaneous T Cell Lymphoma1
Polycythemia Vera1

Other1 trial

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

Tampa, Florida1 trial

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

Moffitt Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.